Nevin Manimala

Pain Manag Nurs. 2024 Mar 12:S1524-9042(24)00019-5. doi: 10.1016/j.pmn.2024.02.009. Online ahead of print.

ABSTRACT

OBJECTIVE: This study aims to investigate the effect of an educational intervention on cancer patients receiving palliative care and their caregivers concerning symptom management and family needs.

METHODS: This study involved 120 participants-60 cancer patients and their respective caregivers-divided into intervention and control groups. Over a 2-week period, the intervention group received a comprehensive educational program focusing on symptom management, while the control group did not receive any educational intervention. The Edmonton Symptom Assessment System (ESAS) and Palliative Performance Scale (PPS) were used to assess patients’ symptoms, their intensity, and performance, while the Family Need Scale (FNS) was utilized to evaluate caregivers’ needs. These assessments were conducted at the beginning and end of the study. Primary outcomes focused on symptom assessment using ESAS and PPS, along with evaluating caregivers’ needs through FNS. Secondary outcomes involved assessing participant satisfaction with the intervention.

RESULTS: At the end of the study, comparing initial and second evaluations, both ESAS and PPS scores significantly increased in the intervention and control groups (p = .003, p = .002, respectively). Additionally, a statistically significant decrease in the severity of symptoms, except for lethargy/hypokinesis, was observed in the intervention group compared to the control group. The FNS scale indicated that family needs satisfaction was higher in the intervention group compared to the control group. The data obtained demonstrated that there was a reduction the pain, fatigue, depression, anxiety, drowsiness, and shortness of breath levels in the intervention group compared to the control group, but there was no significant difference other than these symptoms.

CONCLUSIONS: The educational intervention positively impacted symptom management and family needs. Optimizing symptom control would greatly benefit palliative care patients and their caregivers.

PMID:38480085 | DOI:10.1016/j.pmn.2024.02.009

Curr Pharm Teach Learn. 2024 Mar 12:S1877-1297(24)00060-1. doi: 10.1016/j.cptl.2024.03.001. Online ahead of print.

ABSTRACT

OBJECTIVE: Adverse Childhood Experiences (ACEs) have demonstrated negative impact on physical, emotional, and cognitive health outcomes. This study aimed to assess prevalence of ACEs among Doctor of Pharmacy (PharmD) students, and their associations with mental health, substance use, academic performance, and sleep patterns.

METHODS: A cross-sectional survey was conducted on PharmD students at a private University. ACE scores, mental health history, substance use, academic performance, and sleep habits were self-reported. Descriptive statistics and chi-square tests were used for analysis.

RESULTS: From 54 participants across all cohorts of students in the curriculum (response rate: 19%), 48% reported ≥4 ACEs. A majority of students reported having been diagnosed with or sought treatment for depression (56%) or anxiety (67%), while 42.9% reported a history of contemplating suicide. Participants with ACE scores of ≥4 were more likely to have sought treatment for depression, any mental health condition, contemplated suicide, or used alcohol for mental health purposes. No differences in academic performance based on ACE scores were found.

CONCLUSION: High numbers of ACEs were common and linked to mental illness, suicidality, and use of alcohol for mental health purposes. While no direct academic impact was found in this small sample size, adopting a trauma-informed approach is crucial to supporting student well-being. Further research in this area is needed to optimize interventions to support academic and professional success among students with ≥4 ACEs.

PMID:38480066 | DOI:10.1016/j.cptl.2024.03.001

Am J Surg. 2024 Mar 5:S0002-9610(24)00167-3. doi: 10.1016/j.amjsurg.2024.03.007. Online ahead of print.

ABSTRACT

BACKGROUND: We aimed to investigate the prevalence, characteristics, and management of nephrolithiasis in primary hyperparathyroidism (PHPT) patients.

METHODS: Medical records of patients who underwent parathyroidectomy at a tertiary care hospital in British Columbia from January 2016 to April 2023 were retrospectively reviewed. Demographic data, laboratory results, imaging reports, and urologic consultations were examined. Descriptive statistics and relevant statistical tests, including logistic regressions, were utilized for data analysis.

RESULT: Of the 413 PHPT patients included in the study population, 41.9% harbored renal stones, and nearly half (48.6%) required urological interventions. Male sex, elevated preoperative serum ionized calcium (iCa) and 24-h urinary calcium (24 ​h urine Ca) levels were independent risk factors for stone formation. Additionally, male sex, younger age, and lower preoperative serum 25-hydroxyvitamin D (25(OH)D) level were associated with higher odds of requiring urological intervention for stones.

CONCLUSIONS: This study identified significant prevalence of asymptomatic renal calcifications in PHPT patients, with a substantial proportion necessitating urological intervention. These findings emphasize the importance of incorporating screening and treatment of renal stones into the management of PHPT patients.

PMID:38480062 | DOI:10.1016/j.amjsurg.2024.03.007

Curr Probl Diagn Radiol. 2024 Mar 7:S0363-0188(24)00048-3. doi: 10.1067/j.cpradiol.2024.03.005. Online ahead of print.

ABSTRACT

OBJECTIVE: Adhesive capsulitis (AC) has traditionally been a clinical diagnosis characterized by progressive shoulder pain and decreased range of motion. Our aim is to examine the role of shoulder MRI in making the diagnosis of AC, and to identify the frequency of cases where MRI was the primary method in diagnosing AC amongst medical providers.

METHODS: This was an anonymized retrospective analysis. Patients with positive MRI features suggestive for AC from 2015 to 2018 were included. Pre and post MRI clinical notes were assessed in order to ascertain the clinical suspicion of AC. A total of 117 cases were included for this study.

RESULTS: Our results demonstrated the number of patients whose management were influenced by shoulder MRI. When all of the imaging parameters by MRI are taken into account by aggregate, there is a statistically significant difference (p-value < 0.01) with regards to orthopedists having their working diagnosis of AC confirmed by the MRI results as compared to the primary care physicians.

CONCLUSION: This study supports the role of shoulder MRI in the evaluation of AC. Not only does shoulder MRI assist ordering clinicians with providing additional evidence to support a suspected diagnosis of AC, but also plays a primary role in making the diagnosis of AC in cases in which it was not initially suspected, ultimately impacting management.

PMID:38480061 | DOI:10.1067/j.cpradiol.2024.03.005

Curr Probl Diagn Radiol. 2024 Mar 8:S0363-0188(24)00049-5. doi: 10.1067/j.cpradiol.2024.03.002. Online ahead of print.

ABSTRACT

OBJECTIVE: To determine if gadolinium-based contrast agents increase the sensitivity, specificity or reader confidence of malignant potential in musculoskeletal soft tissue tumors.

METHODS: Pre- and post-contrast MRI studies from 87 patients were read by three independent radiologists of different experience. Readers noted malignant potential and confidence in their diagnosis based on pre-contrast and post-contrast MRI studies. Statistical models assessed for agreement between MRI reader diagnosis and pathologic results as well as analyzing effects of contrast on reader confidence. Inter- and intra-observer variabilities of malignant potential were also calculated.

RESULTS: 87 patients (48 benign and 39 malignant; mean [± SD] age 51 ± 17.9 and 57.1 ± 17.1, respectively) were evaluated. For all readers, pre-contrast and post-contrast sensitivities were 68.1 % and 70.6 % while pre-contrast and post-contrast specificities were 84.6 % and 83.8 %, respectively without significant change (p=0.88). There was not a significant association with the use of contrast and prediction of malignant potential with or without the resident reader (p=0.65 and p=0.82). Use of contrast was significantly associated with higher levels of reader confidence (p=0.02) for all readers. Inter- and intra-observer variabilities were in good agreement (W = 0.77 and 0.70).

CONCLUSION: The addition of a post-contrast sequence increased reader confidence in their diagnosis without a corresponding significant increase in accurate prediction of malignant potential.

PMID:38480060 | DOI:10.1067/j.cpradiol.2024.03.002

Bull Cancer. 2024 Mar 12:S0007-4551(24)00074-2. doi: 10.1016/j.bulcan.2024.01.006. Online ahead of print.

ABSTRACT

INTRODUCTION: Quality of life (QoL) and patient satisfaction are major concerns in oncology.

METHODS: The aim of this prospective observational study was to evaluate these parameters according to the mode of administration of anti-HER2 (subcutaneous [SC] versus intravenous [IV]), the place of administration (Home Hospitalization or HOD versus hospital) for patients supervised by an advanced practice nurse (APN).

RESULTS: Between January 2022 and June 2023, 32 patients were included. They were statistically more satisfied with subcutaneous management (P=0.0004), a result explained by the speed of administration (43.5%), comfort during administration (26%) even though some expressed pain on injection and felt less anxiety (26%). Management by the APN seems more appropriate when anti-HER2 drugs were administered in HOD. In HOD, patients perceived an overall improvement in their quality of life, appetite and cognitive abilities, with a reduction in fatigue, pain and depression (P<0.05). However, the rate of outsourcing to HOD remained too low (30.4%), as 56.3% of patients would have liked to be cared for in HOD if they had had the opportunity.

CONCLUSION: SC administration of anti-HER2 under the supervision of an APN has advantages for the patient, resulting in greatest satisfaction and improved patient QOL, preferably in HOD.

PMID:38480056 | DOI:10.1016/j.bulcan.2024.01.006

Am J Obstet Gynecol. 2024 Feb 29:S0002-9378(24)00005-X. doi: 10.1016/j.ajog.2023.12.038. Online ahead of print.

ABSTRACT

BACKGROUND: National Vital Statistics System reports show that maternal mortality rates in the United States have nearly doubled, from 17.4 in 2018 to 32.9 per 100,000 live births in 2021. However, these high and rising rates could reflect issues unrelated to obstetrical factors, such as changes in maternal medical conditions or maternal mortality surveillance (eg, due to introduction of the pregnancy checkbox).

OBJECTIVE: This study aimed to assess if the high and rising rates of maternal mortality in the United States reflect changes in obstetrical factors, maternal medical conditions, or maternal mortality surveillance.

STUDY DESIGN: The study was based on all deaths in the United States from 1999 to 2021. Maternal deaths were identified using the following 2 approaches: (1) per National Vital Statistics System methodology, as deaths in pregnancy or in the postpartum period, including deaths identified solely because of a positive pregnancy checkbox, and (2) under an alternative formulation, as deaths in pregnancy or in the postpartum period, with at least 1 mention of pregnancy among the multiple causes of death on the death certificate. The frequencies of major cause-of-death categories among deaths of female patients aged 15 to 44 years, maternal deaths, deaths due to obstetrical causes (ie, direct obstetrical deaths), and deaths due to maternal medical conditions aggravated by pregnancy or its management (ie, indirect obstetrical deaths) were quantified.

RESULTS: Maternal deaths, per National Vital Statistics System methodology, increased by 144% (95% confidence interval, 130-159) from 9.65 in 1999-2002 (n=1550) to 23.6 per 100,000 live births in 2018-2021 (n=3489), with increases occurring among all race and ethnicity groups. Direct obstetrical deaths increased from 8.41 in 1999-2002 to 14.1 per 100,000 live births in 2018-2021, whereas indirect obstetrical deaths increased from 1.24 to 9.41 per 100,000 live births: 38% of direct obstetrical deaths and 87% of indirect obstetrical deaths in 2018-2021 were identified because of a positive pregnancy checkbox. The pregnancy checkbox was associated with increases in less specific and incidental causes of death. For example, maternal deaths with malignant neoplasms listed as a multiple cause of death increased 46-fold from 0.03 in 1999-2002 to 1.42 per 100,000 live births in 2018-2021. Under the alternative formulation, the maternal mortality rate was 10.2 in 1999-2002 and 10.4 per 100,000 live births in 2018-2021; deaths from direct obstetrical causes decreased from 7.05 to 5.82 per 100,000 live births. Deaths due to preeclampsia, eclampsia, postpartum hemorrhage, puerperal sepsis, venous complications, and embolism decreased, whereas deaths due to adherent placenta, renal and unspecified causes, cardiomyopathy, and preexisting hypertension increased. Maternal mortality increased among non-Hispanic White women and decreased among non-Hispanic Black and Hispanic women. However, rates were disproportionately higher among non-Hispanic Black women, with large disparities evident in several causes of death (eg, cardiomyopathy).

CONCLUSION: The high and rising rates of maternal mortality in the United States are a consequence of changes in maternal mortality surveillance, with reliance on the pregnancy checkbox leading to an increase in misclassified maternal deaths. Identifying maternal deaths by requiring mention of pregnancy among the multiple causes of death shows lower, stable maternal mortality rates and declines in maternal deaths from direct obstetrical causes.

PMID:38480029 | DOI:10.1016/j.ajog.2023.12.038

J Prosthet Dent. 2024 Mar 12:S0022-3913(24)00128-8. doi: 10.1016/j.prosdent.2024.02.012. Online ahead of print.

ABSTRACT

STATEMENT OF PROBLEM: A trial restoration is an important diagnostic tool that can be fabricated through analog or digital pathways. Digital workflows may have improved accuracy, but this is yet to be demonstrated conclusively.

PURPOSE: The purpose of this in vitro study was to compare the dimensional accuracy of trial restorations produced by different analog (molded) and digital (milled and 3D printed) methods. Parameters studied included fabrication methods, Shore-A hardness of silicone putty indices, length of span, and labial tooth levels.

MATERIAL AND METHODS: Digital additive trial restorations were designed on a single virtual cast from maxillary right to left lateral incisor teeth (4 teeth) and from maxillary right to left first premolar teeth (8 teeth). Both designs were identical on the 4 anterior teeth. Each digital trial restoration was 3-dimensionally (3D) printed to produce reference casts. The original cast was 3D printed to produce 44 replica casts. There were 8 experimental groups (4 analog and 4 digital) with 10 specimens each. For the analog groups, 20 silicone indices per reference cast were made: 10 from standard silicone putty (63 to 70 Shore-A hardness) and 10 from hard silicone putty (90 Shore-A hardness). The analog trial restorations were molded on replica casts with silicone indices and bis-acryl resin. The digital trial restorations were either milled or 3D printed and adapted onto replica casts. Each trial restoration was scanned and digitally superimposed onto respective scanned reference casts. Measurements were recorded at 3 levels: cervical, middle, and incisal. The independent samples Kruskal-Wallis, 2-sample Mann-Whitney, and Bonferroni tests were used to compare the distribution of accuracy among all groups (α=.05).

RESULTS: The dimensional accuracy of the different trial restoration fabrication methods was comparable in terms of median values of trueness (how close the readings were to the reference), and no statistically significant difference was found among them (P>.05). When the dimensional accuracy in terms of precision (how close the readings were to each other) were analyzed, the hard putty groups demonstrated a statistically significant better outcome, whereas standard putty consistently showed the poorest result. The incisal level displayed the most significant deviation (P=.005) when all groups were compared. The incisal discrepancy values of the short-span standard putty trial restoration varied by as much as 0.84 mm in some specimens.

CONCLUSIONS: Milled and 3D printed trial restoration fabrication techniques showed dimensional accuracy comparable with that of the analog groups. However, the choice of silicone putty was shown to affect the dimensional accuracy of an analog molded trial restoration. A high Shore-A hardness silicone putty produced the best precision and should be used when fabricating an analog molded trial restoration.

PMID:38480017 | DOI:10.1016/j.prosdent.2024.02.012

J Prosthet Dent. 2024 Mar 12:S0022-3913(24)00143-4. doi: 10.1016/j.prosdent.2024.02.019. Online ahead of print.

ABSTRACT

STATEMENT OF PROBLEM: Precise data are a prerequisite for accurately fitting restorations. Therefore, intraoral scanners have to be reliable. Data on differences between the same model of intraoral scanning systems are lacking.

PURPOSE: This in vitro study evaluated differences in the scanning accuracy of a partially edentulous maxilla between combinations of new intraoral scanners of a single model from the same manufacturer (Primescan; Dentsply Sirona) and several calibration aids.

MATERIAL AND METHODS: The in vitro reference model simulated a maxilla with 6 prepared teeth for a complete arch fixed partial denture. Five precision ceramic balls were used to detect dimensional deviation between the reference model and the scan. Distances were divided into 4 categories, from short distances between 2 neighboring precision balls to the cross-arch distance with the scan path comprising all 5 balls. For each combination of 4 new intraoral scanners and their respective calibration aids, 12 model registrations were generated. The data were statistically analyzed using ANOVA (α=.05).

RESULTS: Distance deviations increased with increasing scan path length and were significantly affected by the covariates “scanner” (P≤.023) and, for 3 of 4 distance categories, the “calibration aid” (short, medium, and long distances: P≤.013). For short and medium distances, acceptable scanning results were achieved for all test groups. The largest deviation was 539 µm for the cross-arch distance.

CONCLUSIONS: Scanning accuracy depends on the scanner and the calibration aid used, in particular, for spans exceeding a single quadrant.

PMID:38480016 | DOI:10.1016/j.prosdent.2024.02.019

Clin Nutr ESPEN. 2024 Apr;60:362-372. doi: 10.1016/j.clnesp.2024.02.025. Epub 2024 Feb 29.

ABSTRACT

BACKGROUND: Irritable bowel syndrome (IBS) is a common gastrointestinal disease characterized by abdominal pain, distension, and altered bowel habits. Probiotics may alleviate IBS symptoms, but clinical trials remain conflicting.

AIMS: To conduct a systematic review and meta-analysis of clinical trials to evaluate the efficacy and safety of probiotics for IBS patients.

METHODS: We searched relevant trials in PubMed, Web of Science, Embase, Cochrane Library, and Google Scholar from 2000 to June 2023. Standardized mean difference (SMD) and 95% confidence interval (CI) were calculated for continuous outcomes. A risk ratio (RR) and a 95% CI were calculated for dichotomous outcomes.

RESULTS: A total of 20 studies involving 3011 patients were obtained. The results demonstrated that probiotics are more effective than placebo in reducing global IBS symptoms improvement rate (RR = 1.401, 95% CI 1.182-1.662, P < 0.001) and quality of life scores (SMD = 0.286, 95% CI = 0.154-0.418, P < 0.001). Subgroup analyses showed that a shorter treatment time (less than eight weeks) could reduce distension scores (SMD = 0.197, 95% CI = 0.038-0.356, P = 0.015). High doses (daily dose of probiotics ≥ 10ˆ10) or multiple strains of probiotics exhibit beneficial effects on abdominal pain (SMD = 0.412, 95% CI = 0.112-0.711, P = 0.007; SMD = 0.590, 95% CI = 0.050-1.129, P = 0.032; respectively). However, there was no significant benefit on global symptom scores (SMD = 0.387, 95% CI 0.122 to 0.653, P = 0.004) with statistically high inter-study heterogeneity (I2 = 91.9%, P < 0.001). Furthermore, there was no significant inter-group difference in terms of adverse events frequency (RR = 0.997, 95% CI 0.845-1.177, P = 0.973).

CONCLUSION: Probiotics are effective and safe for IBS patients. High doses or multiple probiotic strains seem preferable, but definite conclusions are challenging due to the high heterogeneity. Large-scale, well-designed, and rigorous trials are needed to confirm their effectiveness.

PMID:38479936 | DOI:10.1016/j.clnesp.2024.02.025